BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 78 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $628 | +27.9% | 43,557 | +45.8% | 0.00% | +50.0% |
| Q2 2023 | $491 | +20.9% | 29,874 | +23.1% | 0.00% | 0.0% |
| Q1 2023 | $406 | +19.8% | 24,277 | +10.4% | 0.00% | 0.0% |
| Q4 2022 | $339 | -99.9% | 21,999 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $325,000 | -22.6% | 21,735 | -14.9% | 0.00% | 0.0% |
| Q2 2022 | $420,000 | -10.8% | 25,549 | +8.8% | 0.00% | 0.0% |
| Q1 2022 | $471,000 | +8.8% | 23,480 | +37.5% | 0.00% | 0.0% |
| Q4 2021 | $433,000 | -57.7% | 17,073 | -55.0% | 0.00% | -60.0% |
| Q3 2021 | $1,023,000 | -2.8% | 37,929 | +4.2% | 0.01% | 0.0% |
| Q2 2021 | $1,053,000 | +21.0% | 36,394 | +10.1% | 0.01% | 0.0% |
| Q1 2021 | $870,000 | +23.1% | 33,069 | +33.9% | 0.01% | +25.0% |
| Q4 2020 | $707,000 | +75.9% | 24,692 | +46.4% | 0.00% | +33.3% |
| Q3 2020 | $402,000 | +55.2% | 16,867 | +36.1% | 0.00% | +50.0% |
| Q2 2020 | $259,000 | – | 12,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |